← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2019-11-15

Drug application

FDA Application #

ANDA207104

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2019-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown